BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 28379307)

  • 21. Long-Smoldering T-prolymphocytic Leukemia: A Case Report and a Review of the Literature.
    Gjelberg HK; Helgeland L; Liseth K; Micci F; Sandnes M; Russnes HG; Reikvam H
    Curr Oncol; 2023 Nov; 30(11):10007-10018. PubMed ID: 37999147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. EBMT prospective observational study on allogeneic hematopoietic stem cell transplantation in T-prolymphocytic leukemia (T-PLL).
    Wiktor-Jedrzejczak W; Drozd-Sokolowska J; Eikema DJ; Hoek J; Potter M; Wulf G; Sellner L; Ljungman P; Chevallier P; Volin L; Koc Y; Martin S; Bunjes D; Rovira M; Itälä-Remes M; Foá R; Deconinck E; Gedde-Dahl T; Cornelissen J; Collin M; Brecht A; Patel A; de Groot M; Reményi P; Nagler A; Finke J; Turlure P; Iacobelli S; van Biezen A; Schetelig J; Kröger N; Dreger P
    Bone Marrow Transplant; 2019 Sep; 54(9):1391-1398. PubMed ID: 30664723
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcomes of Intermediate Risk Karyotype Acute Myeloid Leukemia in First Remission Undergoing Autologous Stem Cell Transplantation Compared With Allogeneic Stem Cell Transplantation and Chemotherapy Consolidation: A Retrospective, Propensity-score Adjusted Analysis.
    Limvorapitak W; Barnett MJ; Hogge DE; Forrest DL; Nevill TJ; Narayanan S; Power MM; Nantel SH; Broady R; Song KW; Toze CL; Mourad YA; Sutherland HJ; Gerrie AS; White J; Sanford DS
    Clin Lymphoma Myeloma Leuk; 2018 Nov; 18(11):e481-e491. PubMed ID: 30100330
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [T-cell prolymphocytic leukemia: potential diagnostic pitfalls].
    Dessart P; Lemaire P; Le Dû K; Sandrini J; Prophette B; Maillard H
    Ann Dermatol Venereol; 2014 Dec; 141(12):777-81. PubMed ID: 25433931
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Loss of donor chimerism in remission after allogeneic stem cell transplantation of T-prolymphocytic leukemia patients following alemtuzumab induction therapy.
    Szuszies CJ; Hasenkamp J; Jung W; Koch R; Trümper L; Wulf GG
    Int J Hematol; 2014 Nov; 100(5):425-8. PubMed ID: 25258193
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Salvage therapy in refractory acute myeloid leukemia: prediction of outcome based on analysis of prognostic factors.
    Tavernier E; Le QH; Elhamri M; Thomas X
    Leuk Res; 2003 Mar; 27(3):205-14. PubMed ID: 12537972
    [TBL] [Abstract][Full Text] [Related]  

  • 27. T-Cell Prolymphocytic Leukemia: Diagnosis, Pathogenesis, and Treatment.
    Gutierrez M; Bladek P; Goksu B; Murga-Zamalloa C; Bixby D; Wilcox R
    Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569479
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A pediatric case of T-cell prolymphocytic leukemia.
    Mitton B; Coutre S; Willert J; Schlis K; Porteus M; Kharbanda S; Agarwal-Hashmi R
    Pediatr Blood Cancer; 2015 Jun; 62(6):1061-2. PubMed ID: 25417638
    [TBL] [Abstract][Full Text] [Related]  

  • 29. T-cell prolymphocytic leukemia frequently shows cutaneous involvement and is associated with gains of MYC, loss of ATM, and TCL1A rearrangement.
    Hsi AC; Robirds DH; Luo J; Kreisel FH; Frater JL; Nguyen TT
    Am J Surg Pathol; 2014 Nov; 38(11):1468-83. PubMed ID: 25310835
    [TBL] [Abstract][Full Text] [Related]  

  • 30. T-Cell Prolymphocytic Leukemia With t(X;14)(q28;q11.2): A Clinicopathologic Study of 15 Cases.
    Hu Z; Medeiros LJ; Xu M; Yuan J; Peker D; Shao L; Tang Z; Mai B; Thakral B; Rios A; Hu S; Wang W
    Am J Clin Pathol; 2023 Apr; 159(4):325-336. PubMed ID: 36883805
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Outcome of children with T cell acute lymphoblastic leukemia treated with Chinese Children Leukemia Group acute lymphoblastic leukemia (CCLG-ALL) 2008 protocol].
    Liu XM; Chen XJ; Zou Y; Wang SC; Wang M; Zhang L; Chen YM; Yang WY; Guo Y; Zhu XF
    Zhonghua Er Ke Za Zhi; 2019 Oct; 57(10):761-766. PubMed ID: 31594062
    [No Abstract]   [Full Text] [Related]  

  • 32. Prolymphocytic Leukemia: New Insights in Diagnosis and in Treatment.
    Collignon A; Wanquet A; Maitre E; Cornet E; Troussard X; Aurran-Schleinitz T
    Curr Oncol Rep; 2017 Apr; 19(4):29. PubMed ID: 28324286
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of prolymphocytic leukemia.
    Dearden C
    Hematology Am Soc Hematol Educ Program; 2015; 2015():361-7. PubMed ID: 26637744
    [TBL] [Abstract][Full Text] [Related]  

  • 34. B- and T-cell prolymphocytic leukemia: antibody approaches.
    Dearden C
    Hematology Am Soc Hematol Educ Program; 2012; 2012():645-51. PubMed ID: 23233647
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cerebriform variant type of T cell prolymphocytic leukemia: Report of one case].
    Peña C; Valladares X; Soto C; Encina A; Marinov N; Undurraga MS; Cabrera ME
    Rev Med Chil; 2016 Jan; 144(1):124-8. PubMed ID: 26998991
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cerebriform variant type of T cell prolymphocytic leukemia with complex karyotype including an additional segment at 1p36.1.
    Kasahara S; Tsurumi H; Shibata Y; Matsumoto T; Nakamura N; Nakamura H; Kanemura N; Goto N; Hara T; Moriwaki H
    Int J Hematol; 2012 Nov; 96(5):674-8. PubMed ID: 23054642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cutaneous Presentation of T-Cell Prolymphocytic Leukemia Mimicking Dermatomyositis.
    Ingrasci G; Diaz-Perez J; Verne S; Romanelli P; Yosipovitch G
    Am J Dermatopathol; 2021 Jul; 43(7):521-524. PubMed ID: 33606377
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Up-front autologous stem-cell transplantation in peripheral T-cell lymphoma: NLG-T-01.
    d'Amore F; Relander T; Lauritzsen GF; Jantunen E; Hagberg H; Anderson H; Holte H; Österborg A; Merup M; Brown P; Kuittinen O; Erlanson M; Østenstad B; Fagerli UM; Gadeberg OV; Sundström C; Delabie J; Ralfkiaer E; Vornanen M; Toldbod HE
    J Clin Oncol; 2012 Sep; 30(25):3093-9. PubMed ID: 22851556
    [TBL] [Abstract][Full Text] [Related]  

  • 39. T-cell prolymphocytic leukemia.
    Khot A; Dearden C
    Expert Rev Anticancer Ther; 2009 Mar; 9(3):365-71. PubMed ID: 19275513
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alemtuzumab therapy in T-cell prolymphocytic leukemia: comparing efficacy in a series treated intravenously and a study piloting the subcutaneous route.
    Dearden CE; Khot A; Else M; Hamblin M; Grand E; Roy A; Hewamana S; Matutes E; Catovsky D
    Blood; 2011 Nov; 118(22):5799-802. PubMed ID: 21948296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.